Review
Accepted on 06 Oct 2025
Structure and gating of kainate receptors
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1662316
- 146 views
Type at least 3 characters
545 articles
Original Research
Published on 02 Oct 2025
Electrophysiological classification of CACNA1G gene variants associated with neurodevelopmental and neurological disorders
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1613072
- 2,512 views
Review
Accepted on 30 Sep 2025
Late-Neurodevelopmental Altered GABAergic signaling and chloride homeostasis in Eye Movement Circuits: Insights for Therapeutic Treatments for Alzheimer's Disease
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1675799
- 136 views
Original Research
Published on 24 Sep 2025
Beta-amyloid influences the content and trafficking of beta-amyloid precursor protein via Na,K-ATPase-Src kinase positive feedback loop
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1665715
- 2,928 views
Original Research
Published on 03 Sep 2025
Inhibition of the oncogenic channel Kv10.1 by the antipsychotic drug penfluridol
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1655406
- 2,991 views
Original Research
Published on 02 Sep 2025
The interplay of polarizable water and protein in the activation of the M2 channel
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1532697
- 2,603 views
Original Research
Published on 20 Aug 2025
CFTR ion transport deficiency primes the epithelium for partial epithelial-mesenchymal transition in cystic fibrosis
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1655479
- 2,499 views
Original Research
Published on 04 Aug 2025
Selective amino acid formulation enhances anion secretion and restores function in cystic fibrosis mutations
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1522130
- 2,010 views
Review
Published on 29 Jul 2025
Factors that influence the Na/K-ATPase signaling and function
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1639859
- 1,783 views
Review
Published on 04 Jun 2025
Exploring the ER channel protein Sec61: recent advances in pathophysiological significance and novel pharmacological inhibitors
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1580086
- 2,553 views
Original Research
Published on 21 May 2025
Loss of SynDIG4/PRRT1 alters distribution of AMPA receptors in Rab4- and Rab11-positive endosomes and impairs basal AMPA receptor recycling
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1568908
- 1,353 views
Review
Published on 09 May 2025
The role of transient receptor potential channels in chronic kidney disease-mineral and bone disorder
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1583487
- 2,247 views
Review
Published on 30 Apr 2025
Inhibition of NMDA receptors and other ion channel types by membrane-associated drugs
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1561956
- 3,054 views
- 1 citation
Original Research
Published on 29 Apr 2025
Early reduction of skin potassium without sodium accumulation in the pathogenesis of salt sensitivity in primary aldosteronism
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1575972
- 1,708 views
Original Research
Published on 22 Apr 2025
Gaussian white noise stimulation as an alternative method to excite sensory neurons
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1561905
- 1,355 views
Original Research
Published on 10 Apr 2025
The venom of Cyriopagopus schmidti spider contains a natural huwentoxin-IV analogue with unexpected improved analgesic potential
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1566312
- 1,850 views
- 1 citation